Advertisement
Singapore markets closed

  • Straits Times Index

    3,338.94
    -9.93 (-0.30%)
     

  • S&P 500

    5,283.40
    +5.89 (+0.11%)
     

  • Dow

    38,571.03
    -115.27 (-0.30%)
     

  • Nasdaq

    16,828.67
    +93.67 (+0.56%)
     

  • Bitcoin USD

    68,939.00
    -288.88 (-0.42%)
     

  • CMC Crypto 200

    1,443.66
    -3.49 (-0.24%)
     

  • FTSE 100

    8,227.11
    -35.64 (-0.43%)
     

  • Gold

    2,347.30
    -22.00 (-0.93%)
     

  • Crude Oil

    72.90
    -1.32 (-1.78%)
     

  • 10-Yr Bond

    4.4020
    -0.1120 (-2.48%)
     

  • Nikkei

    38,837.46
    -85.54 (-0.22%)
     

  • Hang Seng

    18,444.11
    +41.11 (+0.22%)
     

  • FTSE Bursa Malaysia

    1,615.40
    +18.72 (+1.17%)
     

  • Jakarta Composite Index

    7,099.31
    +63.12 (+0.90%)
     

  • PSE Index

    6,386.42
    -84.32 (-1.30%)
     

X4 Pharmaceuticals: Q4 Earnings Snapshot

Associated Press
Updated ·1-min read

BOSTON (AP) _ X4 Pharmaceuticals, Inc. (XFOR) on Thursday reported a loss of $18.4 million in its fourth quarter.

The Boston-based company said it had a loss of 91 cents per share.

The results did not meet Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 87 cents per share.

For the year, the company reported that its loss widened to $62.1 million, or $3.09 per share. Revenue was reported as $3 million.

X4 Pharmaceuticals shares have risen 51% since the beginning of the year. The stock has declined nearly 8% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XFOR at https://www.zacks.com/ap/XFOR